# PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk

Study · id `cardio:ct-nct07741253` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07741253](<https://clinicaltrials.gov/study/NCT07741253>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07741253

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 182 participants.

## Technical summary

Registry record NCT07741253. Randomized; single masking; primary purpose treatment. Start 2026-10-25 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 182 participants (planned count; ClinicalTrials.gov record NCT07741253, source copy `cardio:ctgov-nct07741253-2026-10-26`, retrieved 2026-10-31)
- Planned start: 2026-10-25 (anticipated) (ClinicalTrials.gov record NCT07741253, source copy `cardio:ctgov-nct07741253-2026-10-26`, retrieved 2026-10-31)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07741253, source copy `cardio:ctgov-nct07741253-2026-10-26`, retrieved 2026-10-31)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07741253, source copy `cardio:ctgov-nct07741253-2026-10-26`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT07741253, source copy `cardio:ctgov-nct07741253-2026-10-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07741253-2026-10-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
- Acronym: PRECISE-AFMR I
- Condition: Atrial Functional
- Condition: Mitral Regurgitation (MR)
- Intervention (Device): Transcatheter Edge-to-Edge Repair
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV
- Collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Transcatheter edge-to-edge repair (TEER) (`cardio:transcatheter-edge-to-edge-repair`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)
- Registry lists this organization as a collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital (`cardio:org-chinese-academy-of-medical-sciences-fuwai-hospital`)

## Provenance

Content hash: a61425dc565232e850902c8d60ca03974469096cf4b1f9d098e8d9ee2377af53
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
